Stay updated on Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-10T03:00:42.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page now displays a revision tag updated to Revision: v3.4.2, replacing Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-16T16:01:12.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision 3.4.1 was added; the previous funding/operating-status notice associated with Revision 3.4.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-09T12:30:59.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and updated UI labels, including 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', plus a new 'Revision: v3.4.0' tag.
    Difference
    0.1%
    Check dated 2026-01-26T07:52:55.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    A new revision label, Revision: v3.3.4, was added and the previous Revision: v3.3.3 was removed.
    Difference
    0.0%
    Check dated 2026-01-19T06:09:36.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Expanded the study's Locations section to include a comprehensive list of site locations across multiple regions. The update covers locations across the United States, Canada, Australia, and numerous other countries.
    Difference
    2%
    Check dated 2025-12-21T21:30:33.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial page.